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PLENARY SESSIONS ANNOUNCED FOR
TANDEM BMT MEETINGS
The plenary session topics and
speakers have been finalized for the
2005 Tandem BMT Meetings that will
be held Feb. 10–14 at the Keystone
Conference Center in Keystone, Colo.
The Tandem BMT Meetings are the
combined annual meetings of ASBMT
and the Center for International Blood
and Marrow Transplant Research (CIB-
MTR—formerly the IBMTR/ABMTR).
THURSDAY, FEBRUARY 10
Regenerating the Myocardium with
Bone Marrow Cells
● Animal models and clinical trials:
the next steps—Armand Keating
● Bone marrow cells for myocardial
infarction: hope or still hype?—
Helmut Drexler
● Mononuclear bone marrow cells
for the therapy of heart failure—
Emerson C. Perin
FRIDAY, FEBRUARY 11
Stem Cells: Implications for
Therapy
● Complexity of the human AML
stem cell compartment: implica-
tions for therapy—John Dick
● Identification of brain cancer
stem cells—Peter Dirks
● Identification of breast cancer
stem cells—Michael Clark
SATURDAY, FEBRUARY 12
GvHD/Histocompatibility
● Overview of graft-versus-host dis-
ease in allogeneic stem cell trans-
plantation—Olle´ Ringden
● Pathophysiology of graft-versus-
host disease—George Sale
● Histocompatibility and graft-ver-
sus-host disease—John Hansen
SUNDAY, FEBRUARY 13
Innovations in Autologous Stem
Cell Transplantation
● Current status of autologous trans-
plantation: limitations and poten-
tial solutions—Stephen J. Forman
● T-cell immunotherapy following
autologous hematopoietic cell
transplantation—Michael Jensen
● Innovations in regimen develop-
ment for autologous stem cell
transplantation—Frederick Appel-
baum
MONDAY, FEBRUARY 14
Allotransplants: Immune
Reconstitution
● Overview of immunologic failure
after SCT—Joseph Antin
● T-reg cells—Bruce Blazar
● Thymic reconstitution and KGF—
Georg A. Hollander
Additional concurrent scientific ses-
sions and workshops will address
bloodless transfusions, chronic lympho-
cytic leukemia, induction tolerance, my-
elodysplastic and myeloproliferative dis-
eases, non-GvHD complications of
transplants, non-malignant disorders,
radiation in BMT, transplantation for pe-
diatric solid tumors, tumor vaccines, im-
aging, life after relapse, clinical trials
design, and statistical analysis of trans-
plant data.
Online meeting registration and
housing information are available on
the ASBMT Web site, www.asbmt.
org, and the CIBMTR Web site,www.
cibmtr.org.
MEMBERSHIP DUES WAIVED FOR
FELLOWS-IN-TRAINING
Postdoctoral fellows and physi-
cians-in-training for blood and mar-
row transplantation are eligible for
free ASBMT membership.
Annual dues for the 2005 calendar
year will be waived for trainees who
join ASBMT. Usually annual dues are
$75. The program to recruit in-train-
ing members is supported by an un-
restricted educational grant from ESP
Pharma.
Included in ASBMT membership is a
subscription to Biology of Blood and
Marrow Transplantation and the bulle-
tin Blood and Marrow Transplantation
Reviews. A variety of other membership
benefits include reduced member-rate
registration at the Tandem BMT Meet-
ings and access to new investigator
awards and travel grants.
Membership applications are avail-
able from the ASBMT Executive Office
or online at the ASBMT Web site at
www.asbmt.org.
NEW INVESTIGATORS ELIGIBLE FOR
$5,000 EDITORIAL AWARDS
Each year ASBMT presents two ed-
itorial awards to new investigators
published in Biology of Blood and
Marrow Transplantation.
● George Santos Award for best
clinical research article
● Ernest McCulloch & James Till
Award for best basic science article
Both awards are accompanied by a
$5,000 prize that is presented at the
Tandem BMT Meetings. The two
awards are supported by educational
grants from StemCell Technologies
Inc. and StemSoft Software Inc., Van-
couver.
To be eligible, a recipient must be
not more than five years past a grad-
uate or postdoctoral program or a
clinical research fellowship, or cur-
rently active in a training program as
a clinical resident or fellow, postdoc-
toral fellow, medical student, gradu-
ate student or undergraduate stu-
dent. The winning articles must have
been published in the current volume
(2004, Vol. 10) of the journal.
Many authors choose Biology of
Blood and Marrow Transplantation
for submitting basic and clinical re-
search articles because:
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● The readership is highly focused
in the field of hematopoietic pro-
genitor stem cell transplantation.
● The turnaround time from article
acceptance to publication aver-
ages 40 days for a “rapid publi-
cation” and 75 days for a regular
article.
● There are no author page
charges.
● The journal has an ISI Impact
Factor of 2.88, ranking it among
the top 25% of transplant jour-
nals.
The judging committee for the ed-
itorial awards is the BBMT Editorial
Board and ASBMT Publications Com-
mittee.
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